DAYBUE™ (trofinetide), the only FDA approved treatment for Rett syndrome.Click here to learn more  
Currently Neuren does not have the necessary approvals or available drug supply to enable any compassionate use or named patient programs for NNZ-2591

Improving the lives of people with
neurodevelopmental disabilities

So your online presence really delivers at each step

Learn more

Improving the lives of people with
neurodevelopmental disabilities

So your online presence really delivers at each step

Learn more

Improving the lives of people with
neurodevelopmental disabilities

So your online presence really delivers at each step

Learn more

Box Section Title

Products and Pipeline
 

Product Development Pipeline

Products

Investor Information
 
...
Latest News
 
...
Share Price
 
ASX:NEU
..
Market Cap:
20 minute delay